Timeline
February 27, 2026 — March 2, 2026
Health
Timeline: Novartis Settles Lawsuit Over Henrietta Lacks' 'Stolen' Cells
The estate of Henrietta Lacks reached a settlement with pharmaceutical giant Novartis over the unauthorized use of her cells, which were taken without consent in 1951 and became foundational to modern medical research. This timeline tracks the development of this landmark case from its historical origins through the February 2026 settlement announcement, marking the second major corporate settlement for the Lacks family's fight for justice in what they describe as exploitation by a racist medical system.
7 events · 4 days · 16 source articles
Mon, Jan 1, 1951
Major
Henrietta Lacks' Cells Taken Without Consent
Cells were taken from Henrietta Lacks' tumor without her knowledge or permission in 1951. These cells, later known as HeLa cells, would be reproduced in laboratories and become instrumental in major medical advancements, including the development of the polio vaccine. Lacks was a Black patient whose case would later become emblematic of racial injustices in the medical system.
Mon, Oct 4, 2021
Major
Lacks Family Takes Legal Action
Descendants of Henrietta Lacks, including grandsons Ron Lacks and Alfred Lacks Carter, appeared outside the federal courthouse in Baltimore with attorney Ben Crump. The family filed lawsuits against biomedical businesses, accusing them of unjustly profiting from a racist medical system that took advantage of Black patients. This marked the beginning of their legal campaign for compensation.
Sun, Feb 1, 2026
Major
Settlement Agreement Finalized in Federal Court
The settlement between the Henrietta Lacks estate and Novartis was finalized in federal court in Maryland. While the agreement was completed this month, details of the settlement terms were kept confidential and not made public. This represented the culmination of years of legal proceedings against the Swiss-based pharmaceutical giant.
Fri, Feb 27, 2026
Major
Novartis Settlement Publicly Announced
News outlets began reporting that Novartis had settled the lawsuit filed by Henrietta Lacks' estate. The suit alleged that the pharmaceutical giant unjustly profited from her cells. Both the Lacks family and Novartis released a joint statement expressing they were pleased to resolve the matter outside of court, though neither party would comment further on the terms.
Fri, Feb 27, 2026
Moderate
Second Settlement Achieved by Lacks Estate
Reports confirmed that the Novartis settlement represents the second major agreement reached by the Henrietta Lacks estate in their lawsuits against biomedical companies. This indicates the family had previously secured at least one other settlement from companies that profited from HeLa cells, though details of the first settlement were not specified in the coverage.
Sat, Feb 28, 2026
Moderate
Medical Publication Highlights Broader Implications
STAT News, a specialized medical and pharmaceutical publication, reported on the settlement with emphasis on its significance within the broader context of the racist medical system. The coverage framed Novartis as the second company to settle after being accused of profiting from systemic racial injustice in medicine, highlighting the case's importance for biomedical ethics.
Mon, Mar 2, 2026
Minor
Insurance Industry Takes Note of Settlement
Insurance Journal published coverage of the Novartis settlement, indicating that the legal and financial implications of the case extended beyond pharmaceutical companies to related industries. The settlement's impact on corporate liability and compensation for historical medical injustices continued to generate discussion across business sectors days after the initial announcement.
Share this story